Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

Source:http://linkedlifedata.com/resource/pubmed/id/20628086

Download in:

View as

General Info

PMID
20628086